Skip to main content
Michael Ming, MD, Dermatology, Philadelphia, PA

Michael E Ming MD

Dermatopathology


Associate Professor, Dermatology, Perelman School of Medicine

Join to view full profile
  • 3400 Spruce Street2 Rhoads PavilionPhiladelphia, PA 19104

  • Phone+1 215-662-2737

  • Fax+1 215-349-8339

Dr. Ming is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Dermatopathology, 1997 - 1999
  • Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
    Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1994 - 1997
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1993 - 1994
  • Harvard Medical School
    Harvard Medical SchoolClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - Present
  • PA State Medical License
    PA State Medical License 2000 - 2026
  • Dermatology
    American Board of Dermatology Dermatology
  • Dermatopathology
    American Board of Dermatology Dermatopathology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but with Positive Histologic Margins  
    Douglas Grossman, Vijay Balakrishnan, Laura K Ferris, Geoffrey Lim, Suephy C Chen, Meera Brahmbhatt, Susan M Swetter, Emily Y Chu, Nathaniel Fleming, Caroline C Kim, M..., JAMA
  • Timing of Onset of Adverse Cutaneous Reactions Associated with Programmed Cell Death Protein 1 Inhibitor Therapy  
    Tara C Mitchell, Michael E Ming, Leo L Wang, Suzanne McGettigan, Emily Y Chu, Lynn Schuchter, JAMA

Lectures

  • Practical Management of Atypical Melanocytic Lesions 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Press Mentions

  • Guidance on the Clinical Understanding and Use of Long‐Acting Injectable Antipsychotics in Schizophrenia: Hong Kong Consensus Statements
    Guidance on the Clinical Understanding and Use of Long‐Acting Injectable Antipsychotics in Schizophrenia: Hong Kong Consensus StatementsFebruary 8th, 2021
  • Cancer Patients May Experience Delayed Skin Effects of Anti-PD-1 Therapy
    Cancer Patients May Experience Delayed Skin Effects of Anti-PD-1 TherapyJuly 18th, 2018
  • Management Strategies of Academic Pigmented Lesion Clinic Directors in the United States
    Management Strategies of Academic Pigmented Lesion Clinic Directors in the United StatesJanuary 4th, 2018

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: